Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
Status: Enrolling
Updated:  4/27/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
Efficacy of 68Ga-DOTATOC Positron Emission Tomography (PET) CT in Children and Young Adults With Brain Tumors
Status: Enrolling
Updated: 4/27/2017
University of Iowa Hospitals and Clinics
mi
from
Iowa City, IA
Click here to add this to my saved trials
Sensory Processing in Tourette Syndrome
Sensory Processing in Tourette Syndrome
Status: Enrolling
Updated:  4/27/2017
UF Center for Movement Disorders and Neurorestoration
mi
from
Gainesville, FL
Sensory Processing in Tourette Syndrome
Sensory Processing in Tourette Syndrome
Status: Enrolling
Updated: 4/27/2017
UF Center for Movement Disorders and Neurorestoration
mi
from
Gainesville, FL
Click here to add this to my saved trials
The Utility of NIOM During LITT for Refractory MTLE
A Prospective Study of the Utility of Neurophysiologic Intraoperative Monitoring by Stereotactic Depth Electrodes During MRI-guided Laser-interstitial Thermal Therapy for Refractory Mesial Temporal Lobe Epilepsy
Status: Enrolling
Updated:  4/27/2017
Duke Univ Med Ctr
mi
from
Durham, NC
The Utility of NIOM During LITT for Refractory MTLE
A Prospective Study of the Utility of Neurophysiologic Intraoperative Monitoring by Stereotactic Depth Electrodes During MRI-guided Laser-interstitial Thermal Therapy for Refractory Mesial Temporal Lobe Epilepsy
Status: Enrolling
Updated: 4/27/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Early and Long-Term Value of Imaging Brain Metabolism
Status: Enrolling
Updated:  5/1/2017
Mayo Clinic
mi
from
Phoenix, AZ
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Early and Long-Term Value of Imaging Brain Metabolism
Status: Enrolling
Updated: 5/1/2017
Mayo Clinic
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Early and Long-Term Value of Imaging Brain Metabolism
Status: Enrolling
Updated:  5/1/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Early and Long-Term Value of Imaging Brain Metabolism
Status: Enrolling
Updated: 5/1/2017
Cedars-Sinai Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Early and Long-Term Value of Imaging Brain Metabolism
Status: Enrolling
Updated:  5/1/2017
UCLA Medical Center
mi
from
Los Angeles, CA
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Early and Long-Term Value of Imaging Brain Metabolism
Status: Enrolling
Updated: 5/1/2017
UCLA Medical Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Early and Long-Term Value of Imaging Brain Metabolism
Status: Enrolling
Updated:  5/1/2017
Santa Monica-UCLA Medical Center
mi
from
Santa Monica, CA
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Early and Long-Term Value of Imaging Brain Metabolism
Status: Enrolling
Updated: 5/1/2017
Santa Monica-UCLA Medical Center
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Early and Long-Term Value of Imaging Brain Metabolism
Status: Enrolling
Updated:  5/1/2017
Gene E. Myers Cardiac and Vascular Consultants
mi
from
Sarasota, FL
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Early and Long-Term Value of Imaging Brain Metabolism
Status: Enrolling
Updated: 5/1/2017
Gene E. Myers Cardiac and Vascular Consultants
mi
from
Sarasota, FL
Click here to add this to my saved trials
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Early and Long-Term Value of Imaging Brain Metabolism
Status: Enrolling
Updated:  5/1/2017
Lahey Clinic Hospital
mi
from
Burlington, MA
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Early and Long-Term Value of Imaging Brain Metabolism
Status: Enrolling
Updated: 5/1/2017
Lahey Clinic Hospital
mi
from
Burlington, MA
Click here to add this to my saved trials
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Early and Long-Term Value of Imaging Brain Metabolism
Status: Enrolling
Updated:  5/1/2017
University at Buffalo
mi
from
Buffalo, NY
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Early and Long-Term Value of Imaging Brain Metabolism
Status: Enrolling
Updated: 5/1/2017
University at Buffalo
mi
from
Buffalo, NY
Click here to add this to my saved trials
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Early and Long-Term Value of Imaging Brain Metabolism
Status: Enrolling
Updated:  5/1/2017
Medical University of South Carolina
mi
from
Charleston, SC
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Early and Long-Term Value of Imaging Brain Metabolism
Status: Enrolling
Updated: 5/1/2017
Medical University of South Carolina
mi
from
Charleston, SC
Click here to add this to my saved trials
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Early and Long-Term Value of Imaging Brain Metabolism
Status: Enrolling
Updated:  5/1/2017
University of Utah
mi
from
Salt Lake City, UT
Metabolic Cerebral Imaging in Incipient Dementia (MCI-ID)
Early and Long-Term Value of Imaging Brain Metabolism
Status: Enrolling
Updated: 5/1/2017
University of Utah
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated:  5/1/2017
Yale University
mi
from
New Haven, CT
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated:  5/1/2017
University of Miami
mi
from
Miami, FL
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated:  5/1/2017
University of Kansas Medical Center
mi
from
Kansas City, KA
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated:  5/1/2017
University at Buffalo, Buffalo General Medical Center
mi
from
Buffalo, NY
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
University at Buffalo, Buffalo General Medical Center
mi
from
Buffalo, NY
Click here to add this to my saved trials
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated:  5/1/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated:  5/1/2017
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
University of Texas Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated:  5/1/2017
University of Vermont
mi
from
Burlington, VT
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
University of Vermont
mi
from
Burlington, VT
Click here to add this to my saved trials
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated:  5/1/2017
University of Virginia
mi
from
Charlottesville, VA
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
University of Virginia
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated:  5/1/2017
University of Alberta Hospital
mi
from
Edmonton,
Efficacy of Prednisone In the Treatment of Ocular Myasthenia
Efficacy of Prednisone In the Treatment of Ocular Myasthenia: The EPITOME' Study
Status: Enrolling
Updated: 5/1/2017
University of Alberta Hospital
mi
from
Edmonton,
Click here to add this to my saved trials
Home Exercise Intervention in Persons With Multiple Sclerosis
Exercise, Subclinical Atherosclerosis and Walking Mobility in Multiple Sclerosis
Status: Enrolling
Updated:  5/1/2017
University of Illinois at Chicago
mi
from
Chicago, IL
Home Exercise Intervention in Persons With Multiple Sclerosis
Exercise, Subclinical Atherosclerosis and Walking Mobility in Multiple Sclerosis
Status: Enrolling
Updated: 5/1/2017
University of Illinois at Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Southern California Research
mi
from
Beverly Hills, CA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Southern California Research
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Pharmacology Research Institute
mi
from
Encino, CA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Pharmacology Research Institute
mi
from
Encino, CA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Synergy Clinical Research of Escondido
mi
from
Escondido, CA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Synergy Clinical Research of Escondido
mi
from
Escondido, CA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Collaborative Neuroscience Network
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Pharmacology Research Institute
mi
from
Los Alamitos, CA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Pharmacology Research Institute
mi
from
Los Alamitos, CA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Excell Research, Inc.
mi
from
Oceanside, CA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Excell Research, Inc.
mi
from
Oceanside, CA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Artemis Institute for Clinical Research
mi
from
San Diego, CA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
MCB Clinical Research Centers
mi
from
Colorado Springs, CO
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
MCB Clinical Research Centers
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Florida Clinical Research Center, LLC
mi
from
Bradenton, FL
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Gulfcoast Clinical Research
mi
from
Fort Myers, FL
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Gulfcoast Clinical Research
mi
from
Fort Myers, FL
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Broward Research Group
mi
from
Hollywood, FL
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Broward Research Group
mi
from
Hollywood, FL
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Geroge M. Joseph MD, PA
mi
from
Jacksonville Beach, FL
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Geroge M. Joseph MD, PA
mi
from
Jacksonville Beach, FL
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Clinical Neuroscience Solutions, Inc.
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Compass Research North, LLC
mi
from
Leesburg, FL
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Compass Research North, LLC
mi
from
Leesburg, FL
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Florida Clinical Research Center LLC
mi
from
Maitland, FL
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Florida Clinical Research Center LLC
mi
from
Maitland, FL
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Acumentality
mi
from
Melbourne, FL
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Acumentality
mi
from
Melbourne, FL
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Clinical Neuroscience Solutions, Inc
mi
from
Orlando, FL
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Stedman Clinical Trials
mi
from
Tampa, FL
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Stedman Clinical Trials
mi
from
Tampa, FL
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Institute for Advanced Medical Research
mi
from
Alpharetta, GA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Atlanta Center for Medical Research
mi
from
Atlanta, GA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
iResearch Atlanta LLC
mi
from
Decatur, GA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
iResearch Atlanta LLC
mi
from
Decatur, GA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Carman Research
mi
from
Smyrna, GA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Carman Research
mi
from
Smyrna, GA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Goldpoint Clinical Research
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Alpine Clinic
mi
from
Lafayette, IN
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Alpine Clinic
mi
from
Lafayette, IN
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Psychiatric Associates
mi
from
Overland Park, KA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Psychiatric Associates
mi
from
Overland Park, KA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Lake Charles Clinical Trials LLC
mi
from
Lake Charles, LA
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Kennedy Krieger Institute
mi
from
Baltimore, MD
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Kennedy Krieger Institute
mi
from
Baltimore, MD
Click here to add this to my saved trials
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated:  5/1/2017
Massachusetts General Hospital
mi
from
Boston, MA
Open-label Safety Study in Adults With ADHD
A Phase 3, 12-Month, Multicenter, Open-label, Flexibly-dosed, Safety Study of SEP 225289 in Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Status: Enrolling
Updated: 5/1/2017
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials